Expanding the Utility of Antisclerostin Therapy
Expanding the Utility of Antisclerostin Therapy
-
![]()
Corporate Development
ButtonPrivately held company. Since its inception, it has been capitalized using convertible notes, non-dilutive grants, and equity.
-
![]()
Professionals
ButtonOssiFi is developing best in class sclerostin small molecule inhibitors to take advantage of new opportunities to develop safer, more effective bone building therapies.
-
![]()
Distribution List
ButtonSign up to keep updated on OssiFi news.
-
![]()
Careers
ButtonOssiFi takes pride in finding the perfect match for our team. We have created a culture that resonates our innovation.
ABOUT US
OssiFi Therapeutics is an innovative bone-biology company operating at the intersection of therapeutics and medical devices to address significant unmet needs in neurogenic low back pain, fracture repair, and fracture prevention.